Dyspareunia Clinical Trial
— POMPOMOfficial title:
Prospective On Market Patient-reported Outcomes for Milli
NCT number | NCT06397885 |
Other study ID # | CP0004 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | April 30, 2024 |
Est. completion date | April 30, 2025 |
To assess the effectiveness of the Milli device in achieving vaginal intercourse
Status | Recruiting |
Enrollment | 200 |
Est. completion date | April 30, 2025 |
Est. primary completion date | April 30, 2025 |
Accepts healthy volunteers | |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Subject is a female at birth aged =18 years of age - Subject is able to read and understand the approved, informed consent form (ICF) - Subject meets vaginismus and related painful sex/GPPPD criteria as defined in the DSM-5, as confirmed by having one or more of the following for greater than 6 months: - Pelvic pain - Vaginal pain - Pain with vaginal intercourse - Pain with vaginal penetration - Fear or anxiety about vaginal or pelvic pain with vaginal penetration - The inability to achieve vaginal penetration - Subject currently has a sexual partner with a functional penis - Subject is currently seeking vaginal penetration to achieve sexual intercourse - Subject is currently unable to tolerate vaginal penetration to achieve sexual intercourse (Score of =1 on PEQ Question #1) - Subject purchased Milli vaginal dilator - Subject is not contraindicated for Milli vaginal dilator use - Subject is able and willing to comply with study protocol Exclusion Criteria: - Subject has previously participated in any studies by the company in the past 12 months or has used Milli prior to enrollment - Subject is pregnant - Subject has an active pelvic infection (vagina or vulva) - Subject has open wounds in the tissue inside or surrounding the vagina - Subject has an untreated major mental health disorder (e.g., affective disorder, psychosis, PTSD) - Subject has prior history of gender-confirming surgery, vaginal reconstruction surgery, pelvic radiation, and/or vaginal procedures that result in extensive scarring (with the exception of hysterectomy procedures) - Subject or subject's partner experiences other conditions preventing intercourse (e.g., erectile dysfunction, lack of libido) |
Country | Name | City | State |
---|---|---|---|
United States | Materna Clinic | Mountain View | California |
Lead Sponsor | Collaborator |
---|---|
Materna Medical |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Penetration Efficiency Questionnaire | Ability to achieve full vaginal penetration with the penis of the partner (intercourse) as measured by the Penetration Efficiency Questionnaire (Score of =2 on PEQ Question #1) at six months | 6 months | |
Secondary | Penetration Efficiency Questionnaire | Ability to achieve full vaginal penetration with the penis of the partner (intercourse) as | 3 months | |
Secondary | Penetration Efficiency Questionnaire | Improvement in ability to achieve vaginal penetration (intercourse and non-intercourse) as measured by a change in baseline in the overall score on the Penetration Efficiency Questionnaire at 3 and 6 months. | 3 months, 6 months | |
Secondary | Female Sexual Function Index (FSFI) | Improvement in self-reported sexual function as reported on a change in baseline in the Female Sexual Function Index (FSFI) total score at 3 and 6 months. | 3 months, 6 months | |
Secondary | Numerical Rating Scale | Improvement in self-reported pain intensity with intercourse as reported as a change in baseline on a numeric rating scale (NRS) (0= no pain, 10 = worst pain imaginable) at 3 and 6 months | 3 months, 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03935698 -
Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study
|
N/A | |
Recruiting |
NCT03427255 -
CBT Group Treatment for Women With Dyspareunia
|
N/A | |
Completed |
NCT02253173 -
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
|
Phase 3 | |
Completed |
NCT03184077 -
Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair
|
N/A | |
Recruiting |
NCT05445115 -
The Mollie Study, a Study to Evaluate the Safety and Efficacy of the Mollie Medical Device
|
N/A | |
Withdrawn |
NCT03666819 -
Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy
|
Phase 2 | |
Active, not recruiting |
NCT03681678 -
Laser Therapy for Treatment of Urogenital Symptoms in Women
|
||
Completed |
NCT04955418 -
Effects of Epi-no Device on Pelvic Floor Dysfunctions
|
N/A | |
Completed |
NCT05834088 -
Effects of Myofascial Release With and Without Thiele Massage
|
N/A | |
Terminated |
NCT03185169 -
GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors
|
Early Phase 1 | |
Completed |
NCT03307044 -
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
|
N/A | |
Completed |
NCT05617820 -
Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy
|
Phase 3 | |
Recruiting |
NCT03714581 -
Laser Therapy Following Radiotherapy for Gynecological Cancer
|
N/A | |
Completed |
NCT04659668 -
Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina.
|
N/A | |
Completed |
NCT03199534 -
A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction
|
Phase 4 | |
Completed |
NCT00318500 -
Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
|
Phase 2 | |
Recruiting |
NCT05540353 -
Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients With Endometriosis.
|
N/A | |
Completed |
NCT03178825 -
Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause
|
N/A | |
Completed |
NCT04389489 -
Postpartum Sexual Function in Pregnant Women With COVID-19
|
||
Completed |
NCT03372720 -
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
|
N/A |